Drugs Made In America Acquisition Corp. (DMAAU) Return on Assets (2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Return on Assets came in at 0.0% in Q4 2025, up 2.69% on a QoQ basis from 0.0% in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Return on Assets (2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 1 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.
- Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.0%, changed N/A from the prior year.
- Return on Assets rose to 0.0% in Q4 2025, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |